Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04502030 |
|---|---|
| Brief Title: | Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study) |
| First Submitted : | August 4, 2020 |
| First Submitted that Met QC Criteria : | August 4, 2020 |
| First Posted : | August 6, 2020 |
| Last Update Submitted that Met QC Criteria : | May 15, 2024 |
| Last Update Posted : | May 20, 2024 (Estimate) |